|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Meazza C and Scanagatta P: Metastatic
osteosarcoma: A challenging multidisciplinary treatment. Expert Rev
Anticancer Ther. 16:543–556. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Venkatramani R, Murray J, Helman L, Meyer
W, Hicks MJ, Krance R, Lau C, Jo E and Chintagumpala M: Risk-based
therapy for localized osteosarcoma. Pediatr Blood Cancer.
63:412–417. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Y, Wang Z and Gemeinhart RA:
Progress in microRNA delivery. J Control Release. 172:962–974.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lages E, Ipas H, Guttin A, Nesr H, Berger
F and Issartel JP: MicroRNAs: Molecular features and role in
cancer. Front Biosci (Landmark Ed). 17:2508–2540. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Connett P: Water fluoridation: Is fluoride
chemophobia? Br Dent J. 222:323–324. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Y, Zhang J, Zhang L, Si M, Yin H and Li
J: Diallyl trisulfide inhibits proliferation, invasion and
angiogenesis of osteosarcoma cells by switching on suppressor
microRNAs and inactivating of Notch-1 signaling. Carcinogenesis.
34:1601–1610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Althoff K, Lindner S, Odersky A, Mestdagh
P, Beckers A, Karczewski S, Molenaar JJ, Bohrer A, Knauer S,
Speleman F, et al: miR-542-3p exerts tumor suppressive functions in
neuroblastoma by downregulating survivin. Int J Cancer.
136:1308–1320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai J, Zhao J, Zhang N, Xu X, Li R, Yi Y,
Fang L, Zhang L, Li M, Wu J and Zhang H: MicroRNA-542-3p suppresses
tumor cell invasion via targeting AKT pathway in human astrocytoma.
J Biol Chem. 290:24678–24688. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J, Wang S, Han F, Li J, Yu L, Zhou
P, Chen Z, Xue S, Dai C and Li Q: MicroRNA-542-3p suppresses
cellular proliferation of bladder cancer cells through
post-transcriptionally regulating survivin. Gene. 579:146–152.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen X, Si Y, Yang Z, Wang Q, Yuan J and
Zhang X: MicroRNA-542-3p suppresses cell growth of gastric cancer
cells via targeting oncogene astrocyte-elevated gene-1. Med Oncol.
32:3612015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li H, Liu H, Pei J, Wang H and Lv H:
miR-542-3p overexpression is associated with enhanced osteosarcoma
cell proliferation and migration ability by targeting Van Gogh-like
2. Mol Med Rep. 11:851–856. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Huang JW, Castella M, Huntsman DG
and Taniguchi T: p53 is positively regulated by miR-542-3p. Cancer
Res. 74:3218–3227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sterne JA, Sutton AJ, Ioannidis JP, Terrin
N, Jones DR, Lau J, Carpenter J, Rücker G, Harbord RM, Schmid CH,
et al: Recommendations for examining and interpreting funnel plot
asymmetry in meta-analyses of randomised controlled trials. BMJ.
343:d40022011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu B, Li J, Zheng M, Ge J, Li J and Yu P:
MiR-542-3p exerts tumor suppressive functions in non-small cell
lung cancer cells by upregulating FTSJ2. Life Sci. 188:87–95. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tao J, Liu Z, Wang Y, Wang L, Yao B, Li Q,
Wang C, Tu K and Liu Q: MiR-542-3p inhibits metastasis and
epithelial-mesenchymal transition of hepatocellular carcinoma by
targeting UBE3C. Biomed Pharmacother. 93:420–428. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rang Z, Yang G, Wang YW and Cui F:
miR-542-3p suppresses invasion and metastasis by targeting the
proto-oncogene serine/threonine protein kinase, PIM1, in melanoma.
Biochem Biophys Res Commun. 474:315–320. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Salinas-Souza C, De Andrea C, Bihl M,
Kovac M, Pillay N, Forshew T, Gutteridge A, Ye H, Amary MF,
Tirabosco R, et al: GNAS mutations are not detected in parosteal
and low-grade central osteosarcomas. Mod Pathol. 28:1336–1342.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang Z, Chen Y, Fu Y, Yang Y, Zhang Y,
Chen Y and Li D: Meta-analysis of differentially expressed genes in
osteosarcoma based on gene expression data. BMC Med Genet.
15:802014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Seong BK, Lau J, Adderley T, Kee L,
Chaukos D, Pienkowska M, Malkin D, Thorner P and Irwin MS: SATB2
enhances migration and invasion in osteosarcoma by regulating genes
involved in cytoskeletal organization. Oncogene. 34:3582–3592.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Geng S, Gu L, Ju F, Zhang H, Wang Y, Tang
H, Bi Z and Yang C: MicroRNA-224 promotes the sensitivity of
osteosarcoma cells to cisplatin by targeting Rac1. J Cell Mol Med.
20:1611–1619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tan ML, Shao P, Friedhuber AM, van Moorst
M, Elahy M, Indumathy S, Dunstan DE, Wei Y and Dass CR: The
potential role of free chitosan in bone trauma and bone cancer
management. Biomaterials. 35:7828–7838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li H, He Y, Hao P and Liu P:
Identification of characteristic gene modules of osteosarcoma using
bioinformatics analysis indicates the possible molecular
pathogenesis. Mol Med Rep. 15:2113–2119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kovacs E, Zorn JA, Huang Y, Barros T and
Kuriyan J: A structural perspective on the regulation of the
epidermal growth factor receptor. Annu Rev Biochem. 84:739–764.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Biscaglia F, Rajendran S, Conflitti P,
Benna C, Sommaggio R, Litti L, Mocellin S, Bocchinfuso G, Rosato A,
Palleschi A, et al: Enhanced EGFR targeting activity of plasmonic
nanostructures with engineered GE11 peptide. Adv Healthc Mater.
6:2017.doi: 10.1002/adhm.201700596. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hou CH, Lin FL, Tong KB, Hou SM and Liu
JF: Transforming growth factor alpha promotes osteosarcoma
metastasis by ICAM-1 and PI3K/Akt signaling pathway. Biochem
Pharmacol. 89:453–463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang T, Li J, Yin F, Lin B, Wang Z, Xu J,
Wang H, Zuo D, Wang G, Hua Y and Cai Z: Toosendanin demonstrates
promising antitumor efficacy in osteosarcoma by targeting STAT3.
Oncogene. 36:6627–6639. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tang F, Wang Y, Hemmings BA, Rüegg C and
Xue G: PKB/Akt-dependent regulation of inflammation in cancer.
Semin Cancer Biol. 48:62–69. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu YR, Zhou XZ, Zhu LQ, Yao C, Fang JF,
Zhou F, Deng XW and Zhang YQ: The anti-cancer activity of the
mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models.
Oncotarget. 7:49527–49538. 2016.PubMed/NCBI
|
|
31
|
Han XG, Li Y, Mo HM, Li K, Lin D, Zhao CQ,
Zhao J and Tang TT: TIMP3 regulates osteosarcoma cell migration,
invasion, and chemotherapeutic resistances. Tumour Biol.
37:8857–8867. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zucchini C, Manara MC, Pinca RS, De
Sanctis P, Guerzoni C, Sciandra M, Lollini PL, Cenacchi G, Picci P,
Valvassori L and Scotlandi K: CD99 suppresses osteosarcoma cell
migration through inhibition of ROCK2 activity. Oncogene.
33:1912–1921. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Siegel DH, Cottrell CE, Streicher JL,
Schilter KF, Basel DG, Baselga E, Burrows PE, Ciliberto HM,
Vigh-Conrad KA, Eichenfield LF, et al: Analyzing the genetic
spectrum of vascular anomalies with overgrowth via cancer genomics.
J Invest Dermatol. 138:957–967. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiang ZH, Peng J, Yang HL, Fu XL, Wang JZ,
Liu L, Jiang JN, Tan YF and Ge ZJ: Upregulation and biological
function of transmembrane protein 119 in osteosarcoma. Exp Mol Med.
49:e3292017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu Z, Piao L, Zhuang M, Qiu X, Xu X,
Zhang D, Liu M and Ren D: Silencing of histone methyltransferase
NSD3 reduces cell viability in osteosarcoma with induction of
apoptosis. Oncol Rep. 38:2796–2802. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guzman-Perez V, Bumke-Vogt C, Schreiner M,
Mewis I, Borchert A and Pfeiffer AF: Benzylglucosinolate derived
isothiocyanate from tropaeolum majus reduces gluconeogenic gene and
protein expression in human cells. PLoS One. 11:e01623972016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guan H, Tan P, Xie L, Mi B, Fang Z, Li J,
Yue J, Liao H and Li F: FOXO1 inhibits osteosarcoma oncogenesis via
Wnt/β-catenin pathway suppression. Oncogenesis. 4:e1662015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dasgupta B and Chhipa RR: Evolving lessons
on the complex role of AMPK in normal physiology and cancer. Trends
Pharmacol Sci. 37:192–206. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zheng L, Yang W, Wu F, Wang C, Yu L, Tang
L, Qiu B, Li Y, Guo L, Wu M, et al: Prognostic significance of AMPK
activation and therapeutic effects of metformin in hepatocellular
carcinoma. Clin Cancer Res. 19:5372–5380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cho SY, Lee HJ, Lee HJ, Jung DB, Kim H,
Sohn EJ, Kim B, Jung JH, Kwon BM and Kim SH: Activation of
AMP-activated protein kinase α and extracelluar signal-regulated
kinase mediates CB-PIC-induced apoptosis in hypoxic SW620
colorectal cancer cells. Evid Based Complement Alternat Med.
2013:9743132013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao Z, Yin JQ, Wu MS, Song G, Xie XB, Zou
C, Tang Q, Wu Y, Lu J, Wang Y, et al: Dihydromyricetin activates
AMP-activated protein kinase and P38(MAPK) exerting antitumor
potential in osteosarcoma. Cancer Prev Res (Phila). 7:927–938.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hu K, Dai HB and Qiu ZL: mTOR signaling in
osteosarcoma: Oncogenesis and therapeutic aspects (Review). Oncol
Rep. 36:1219–1225. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kureel J, Dixit M, Tyagi AM, Mansoori MN,
Srivastava K, Raghuvanshi A, Maurya R, Trivedi R, Goel A and Singh
D: miR-542-3p suppresses osteoblast cell proliferation and
differentiation, targets BMP-7 signaling and inhibits bone
formation. Cell Death Dis. 5:e10502014. View Article : Google Scholar : PubMed/NCBI
|
